Cervical cancer is increasingly recognised as a critical public health challenge in Canada, with experts labelling it as the “fastest-rising form of cancer” in the country. During a press conference held on Wednesday by the Society of Gynecologic Oncology of Canada in Ottawa, medical professionals urged the federal government to take decisive action to combat this “silent national health crisis.” This call to action comes despite a July 2025 federal action plan aimed at eradicating cervical cancer as a public health issue by 2040.
A Stark Warning from Medical Professionals
Dr. Shannon Salvador, the president of the Society of Gynecologic Oncology of Canada, conveyed a sobering message during the event. “Canada is currently facing a silent national health crisis,” she stated, highlighting the disconnect between advancements in medical technology and the rising prevalence of cervical cancer. Dr. Salvador noted that in 2025 alone, approximately 1,650 Canadians were expected to be diagnosed with cervical cancer, with around 430 succumbing to the disease, which she emphasised is largely preventable.
The reliance on traditional Pap testing has not kept pace with medical advancements, and the uptake of the human papillomavirus (HPV) vaccine remains insufficient. Dr. Salvador pointed out that the current vaccination completion rate is stagnating at 64 per cent, a figure she described as “far below the target needed for elimination.”
“This statistic is not just a medical failure; it is a policy failure,” Dr. Salvador stated emphatically.
Shifting the Approach to Screening
In light of these alarming statistics, the Society of Gynecologic Oncology of Canada is advocating for a significant overhaul in cervical cancer screening methods. They are calling for the immediate adoption of HPV DNA testing and the introduction of self-collection kits for HPV screening. These kits would allow individuals to collect samples in the comfort of their own homes, thereby addressing existing barriers such as geographical isolation, historical trauma, and the lack of access to healthcare providers.
According to the Canadian Cancer Society, HPV testing can be performed via a swab from the cervix or vagina. The introduction of self-administered tests represents a progressive step towards increasing accessibility, especially for those in rural, Indigenous, and underserved communities.
Dr. Sarah Kean, provincial lead for cervical cancer in Manitoba, highlighted the disparities faced by Indigenous women, who are diagnosed at higher rates and often experience more advanced stages of the disease. “This is not due to biology,” she stated. “It is due to barriers, lack of access to screening resources, and systemic inequities in healthcare.”
The Financial Burden of Cervical Cancer
The financial implications of cervical cancer are also significant. Dr. Salvador pointed out that the cost of treating cervical cancer in Canada was estimated at $132 million in 2024. Meanwhile, the investment required to screen eligible Canadians over a five-year period would amount to $106 million. The figures illustrate not only the human cost of this disease but also the strain it places on the healthcare system.
Despite the ongoing commitment by Canada and the World Health Organization (WHO) to eliminate cervical cancer, progress remains stagnant. The Canadian Cancer Society’s report from November 2025 indicated that cervical cancer is now the “fourth most diagnosed cancer” and a leading cause of cancer-related deaths among females globally.
The Path Forward: A Call for Comprehensive Solutions
Dr. Kean emphasised that eliminating cervical cancer hinges on three essential pillars: vaccination, HPV-based DNA screening, and access to appropriate treatment. Despite all other forms of cancer in Canada showing a decline in incidence, cervical cancer remains a troubling outlier—one that is entirely preventable.
The call for a robust and accessible HPV screening programme is more pressing than ever. “Robust HPV screening must mean more than just updating guidelines; it requires universal access to primary HPV testing across all provinces and territories,” Dr. Kean asserted.
Why it Matters
The rising incidence of cervical cancer in Canada is a clarion call for immediate action from policymakers and health authorities. The intersection of healthcare accessibility, public health policy, and the urgent need for a comprehensive screening strategy highlights a critical juncture in the battle against this preventable disease. Failure to address these issues will not only lead to increased morbidity and mortality but also exacerbate existing health disparities, particularly among vulnerable populations. As we move forward, it is imperative that Canada implements the necessary changes to ensure that cervical cancer does not emerge as a long-term health crisis.
